Enterome

Developer of immunomodulatory drugs targeting cancer and immune diseases

placeParis, Ile De France, France calendar_todayFounded 2008 groups70 employees language enterome.com

Innovation

13 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 670 times.

YearFilings
20141
20151
20163
20173
20186
20196
20205
20213
20222
20233
20243
20252

Social engagement

Social engagement: 17.1K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

12 investors on record; lead investors include Seventure Partners, Lundbeck Foundation, Symbiosis, Takeda.

Investor typeCountShare
Venture capital325%
Private equity433%
Other / undisclosed542%

Recent activity

24 Jun 2026
Event
BIO 2026
28 May 2026
Milestone
regulatory
12 May 2026
Event
European Hematology Association (EHA) Congress
Coming soon